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ABSTRACT: An absolute quantitation method for measuring free
human milk oligosaccharides (HMOs) in milk samples was
developed using multiple reaction monitoring (MRM). To obtain
the best sensitivity, the instrument conditions were optimized to
reduce the source and postsource fragmentation prior to the
quadrupole transmission. Fragmentation spectra of HMOs using
collision-induced dissociation were studied to obtain the best
characteristic fragments. At least two MRM transitions were used
to quantify and identify each structure in the same run. The
fragment ions corresponded to the production of singly charged
mono-, di-, and trisaccharide fragments. The sensitivity and
accuracy of the quantitation using MRM were determined, with
the detection limit in the femtomole level and the calibration range spanning over 5 orders of magnitude. Seven commercial
HMO standards were used to create calibration curves and were used to determine a universal response for all HMOs. The
universal response factor was used to estimate absolute amounts of other structures and the total oligosaccharide content in milk.
The quantitation method was applied to 20 human milk samples to determine the variations in HMO concentrations from
women classified as secretors and nonsecretors, a phenotype that can be identified by the concentration of 2′-fucosylation in their
milk.
Multiple reaction monitoring (MRM) on a triple quadru-pole instrument (QqQ) is valued for its ability to
quantify low-abundant compounds in complicated mixtures. As
a result, it is widely used for quantitation of small molecules
such as drugs1,2 and metabolites,3,4 and even larger
biomolecules such as proteins, which are digested to
peptides.5−7 However, its application to complicated and labile
biomolecules such as oligosaccharides and glycoconjugates is
still limited.8−10 One challenge is that the masses of
oligosaccharides can be large, up to 5000 Da. The quadrupoles
typically have limited transmission mass ranges such that large
m/z ions are not effectively transmitted. Large peptides of that
size are typically neglected in MRM in favor of smaller peptides
from the same proteins; however, this option is not possible
with glycans. A more practical concern is that commercial QqQ
are most often optimized for peptides and small robust
analytes, while oligosaccharides tend to fragment more readily
during ionization and may not be well-represented by their
quasimolecular ions.
Human milk is an important source for bioactive
oligosaccharides and glycoconjugates. Human milk oligosac-
charides (HMOs) are the third most abundant group of
compounds after lactose and fat, with as much as 5−23 g/L in
milk.11−13 Interestingly, HMOs are produced by mothers not
for direct nourishment of their infants,14 but instead have other
biological functions such as inhibiting the binding of pathogens,
stimulating the growth of commensal intestinal bacterial, and
promoting postnatal brain development.13,15−17 To date, over
200 HMOs have been reported,18−21 and it has been found that
HMO structures are related to their biological functions. For
example, lacto-N-tetraose (LNT) and lacto-N-fucopentaose II
and III (LNFP-II, III) were found to reduce Entamoeba
histolytica attachment and cytotoxicity, while lacto-N-fucopen-
taose I (LNFP-I), an isomer of LNFP-II and LNFP-III, had no
such effects.22 It has also been found that specific bifidobacterial
strains, commensal bacteria found in the gut of healthy infants,
selectively consumed distinct HMO structures.23 For these
reasons, accurate and sensitive quantitation methods capable of
monitoring HMO structures would be very useful for functional
studies.
The absolute quantitation of HMOs is challenging due to the
lack of standards and the difficulty in achieving complete
chromatographic resolution of individual structures. High-
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performance anion-exchange chromatography (HPAEC)
coupled with a pulsed amperometric detector (PAD) is a
common technique for oligosaccharide quantitation.24−27
HPLC separation in combination with spectrophotometric
detection is also available for derivatized oligosaccharides.28−31
However, none of these detection methods are structural
selective, and the quantitation depends on effective chromato-
graphic separation. Multiple reaction monitoring on a QqQ
provides the possibility of a robust label-free method for
quantitation. Its detection can also be structure-selective.
However, it has not been widely used to monitor free
oligosaccharides in milk. One exception is a very recent
example employing negative mode MRM for the absolute
quantitation for six acidic bovine milk oligosaccharides (BMO)
using hydrophilic interaction chromatography (HILIC).32 Low-
femtomole detection limits, which are 3 orders of magnitude
lower than those of the PAD detector, illustrated the value of
MRM for quantifying oligosaccharides. The only other example
employed negative mode MRM to determine eight soluble milk
oligosaccharides in rat serum using normal phase liquid
chromatography.33
In this study, we present a comprehensive MRM analysis of
HMOs. HMOs differ from other milk oligosaccharides such as
BMOs in terms of their structural complexity and diversity and
in their natural abundances.19,20,34 HMOs are more abundant
than BMOs and have a much higher degree of fucosylation than
BMOs. Conversely, BMOs have a much higher degree of
sialylation. Furthermore, the mass spectrometry conditions
were optimized particularly for free oligosaccharides to achieve
high MRM sensitivity, thus enabling the detection of HMO
over a wider dynamic range. The optimized method was then
applied to study the variation in HMO concentrations in milk
collected from healthy mothers. It is known that HMO profiles
are greatly affected by the mother’s secretor phenotype, which
is encoded by the fucosyltransferase 2 (FUT2) gene and causes
the secretion of α(1−2) fucosylation.35 This MRM method was
then used to examine the absolute concentrations of individual
structures to determine the variation in α(1−2) fucosylation
and the total HMO content between mothers of different
secretor phenotypes.
■ EXPERIMENTAL PROCEDURES
A brief description of the experimental procedures is given here.
A more detailed description of the materials and methods used
can be found in the Supporting Information.
Samples and Materials. Milk oligosaccharide standards,
lacto-N-tetraose (LNT), lacto-N-fucopentaose I (LNFP-I),
sialyllacto-N-tetraose c (LSTc), 3′-sialyllactose (3′-SL), and
6′-sialyllactose (6′-SL), 2′-fucosyllactose (2′-FL), and lacto-N-
hexaose (LNH) were purchased to build the standard
calibration curves. Milk samples were obtained from 20 healthy
women who gave birth to healthy full term infants enrolled in
the UC Davis Foods for Health Institute lactation study. The
participants’ secretor statuses were determined by measuring
specific fucosylated HMO structures in their milk as previously
described.36 Ten secretor and 10 nonsecretor participants were
chosen for this study.
Sample Preparation. HMOs were extracted from milk
samples and reduced using the method described previ-
ously.18,36 Briefly, 100 μL of raw milk was defatted via
centrifuge followed by an ethanol precipitation. The defatted
samples were reduced using NaBH4 at 65 °C water bath for 1.5
h followed by a solid phase extraction (SPE) cleanup using
graphitized carbon cartridges. The lyophilized samples were
reconstituted in 100 μL of Nanopure water and diluted by 20-
folds for MS analysis. Oligosaccharide standards were also
reduced using NaBH4. The lyophilized reduced oligosaccharide
standards were weighed using a microbalance (Mettler Toledo,
XP26), reconstituted, and diluted to create standard calibration
curves. A standard addition experiment was performed for one
of the milk samples by adding varying amount of HMO
standards into the 20× diluted extracted milk oligosaccharide
sample.
LC−ESI-MS Analysis. Human milk oligosaccharides were
quantified using an Agilent 6490 triple quadrupole equipped
with an Agilent 1290 infinity LC system, and a Thermo 100 ×
2.1 mm Hypercarb column with a 10 × 2.1 mm Hypercarb
precolumn (particle size of 3 μm for both columns). A 55 min
LC separation was performed using a binary gradient at 0.2
mL/min flow rate: solvent A of 3% acetonitrile, 0.1% formic
acid; solvent B of 90% acetonitrile, 0.1% formic acid in
Nanopure water (v/v). For the initial optimization of the mass
analyzer, pure standards were ran on fast LC gradients (10
min) employing the same solvent composition as described.
The MS was operated in positive mode. The first and third
quadrupoles were operated at unit resolution. The following
parameters were optimized for oligosaccharide analysis: drying
gas temperature and sheath gas temperature 150 °C, drying gas
flow rate 11 L/min, sheath gas flow rate 7 L/min, nebulizer
pressure 25 psi, capillary voltage 1800 V, fragmentor voltage
250 V; rf voltage amplitudes of high-pressure and low-pressure
ion funnels are 100 and 60 V, respectively.
Statistical Analysis. The box-and-whisker plot and statistic
tests were performed in JMP 10.0 statistical software. One-
tailed Student t test (α = 0.05) was used to compare the means
of secretor and nonsecretor groups. Data sets were tested for
homoscedasticity using Bartlett tests, with an α value of 0.05.
Nonhomoscedastic distributions were transformed using
logarithmic functions to meet assumptions for parametric
testing. Distributions that were not normal or homoscedastic
were analyzed by a nonparametric Mann−Whitney−Wilcoxon
method.
■ RESULTS AND DISCUSSION
A method for the accurate absolute quantitation of free
oligosaccharides using MRM was developed by first optimizing
ionization conditions for oligosaccharides. The fragmentation
conditions under collision-induced dissociation (CID) were
also optimized, and the common fragments were determined.
The MS instrument parameters required further optimization
for HMOs because they are structurally labile compared to
metabolites and peptides. Chromatographic separation of
reduced HMOs was performed with porous graphitized carbon
(PGC). Each HMO compound was identified on the basis of its
characteristic fragments and its elution time using a previously
developed annotated HMO library.19,20
Method Optimization. Minimization of In-Source and
Postsource Fragmentation. Oligosaccharides are biomolecules
consisting of monosaccharides linked via glycosidic bonds.19
Triple quadrupole MS (QqQ) has been primarily applied to
small metabolites2,37 and peptides,38,39 which tend to be
intrinsically more stable than oligosaccharides under most
common ionization techniques. Commercial instruments are
often optimized for small molecules and peptides but not for
oligosaccharides. An MS scan of the LNT standard using the
manufacturer default setting (Figure 1a) shows that the
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quasimolecular ions degrade into fragments prior to and during
source extraction resulting in low MRM sensitivity.
To increase the specificity and sensitivity of the detection,
minimizing fragmentation during ion transmission and prior to
the collision-induced dissociation is necessary. While the
optimization process is instrument-specific the principle is the
same for all instruments, i.e., decrease the fragmentation while
maintaining quasimolecular ion abundances. Furthermore, the
dual ion funnel feature makes this instrument still unique
among triple quadrupole instruments making the discussion of
the optimization highly relevant. Several parameters decrease
the internal energy of the ion for this instrument including the
source gas temperature and flow, nebulizer voltage, capillary
voltage, fragmentor voltage, and dual ion funnel voltages. These
parameters were optimized using oligosaccharide standards.
Both reduced and unreduced compounds were examined and
yielded similar responses. The results with LNT are shown as
representative of the entire effort. Optimization of the gas
temperature, fragmentor voltage, and the dual ion funnel
voltage were most effective in increasing the quasimolecular ion
as illustrated in Figure 2. Generally, higher gas temperature
during electrospray ionization (ESI) decreases the formation of
cluster ions, but may increase the internal energy of the ion and
result in in-source fragmentation. Figure 2a shows that the
optimum temperature is around 150 °C for producing the
highest quasimolecular signal.
The fragmentor voltage is the voltage placed at the exit of the
capillary to transmit ions into the mass analyzer. Higher
voltages facilitate the transmission, but can also cause in-source
CID. As shown in Figure 2b, a fragmentor voltage of 250 V
provides the least fragmentation and thus the highest
quasimolecular ion signal. However, 250 V is the minimum
setting on this instrument and it is possible that lower voltages
may still yield higher molecular ion abundances. The triple
quadrupole used in this analysis was equipped with two ion
Figure 1. Response of the method to LNT. (a) The manufacturer
default conditions for peptides produced a large amount of unintended
LNT fragments (m/z 366) in the MS scan mode. (b) After the
instrument optimization, the fragment ion signal was diminished and
the quasimolecular ion was increased: blue squares, GlcNAc (N-
acetylglucosamine); blue circles, Glc (glucose); yellow circles, Gal
(galactose).
Figure 2. Optimization of collision conditions with LNT. (a) The drying gas and sheath gas were maintained at the same temperature. The optimal
temperature at 150 °C provides the strongest quasimolecular ion signal. (b) Fragmentor voltage of 250 V provides the lowest degree of
fragmentation and the strongest quasimolecular ion signal; 250 V is the minimum setting in this instrument. (c) The rf amplitude of the low-pressure
ion funnel at 60 V provides the strongest quasimolecular ion signal. (d) The rf amplitude of the high ion funnel at 100 V provides the lowest degree
of fragmentation. The optimum settings are thus 100 and 60 V for the high-pressure and low-pressure ion funnels, respectively. Red triangle: the
symbol corresponds to the ratio of the quasimolecular ion (m/z 708) counts to the total ion counts. Blue diamond: the symbol corresponds to the
ratio of the fragment ion (m/z 366) counts to the quasimolecular ion (m/z 708) counts. Instrument optimization of the low-pressure ion funnel was
performed with rf amplitude at 40 (black triangles), 60 (green circles), and 80 V (red squares), respectively.
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funnels placed consecutively to focus and transmit ions into the
MS with high efficiency. The ion funnel consists of a series of
concentric electrodes with an applied radio frequency (rf) to
compress the ion cloud, and a dc electrical field to transmit ions
into the mass analyzers.40,41 The ion funnels are used under
relatively high pressures. An appropriate level of neutral gas
inside the funnels is beneficial for ion confinement through
collisional cooling; however, the gas can also increase the
potential for unintended CID. The suggested manufacturer
conditions involved pressures of 7−14 Torr (first ion funnel,
also called high-pressure ion funnel) and 1−3 Torr (second ion
funnel, also called low-pressure ion funnel). Under these
conditions, large amounts of postsource fragmentation were
found using the default rf amplitudes. Decreasing the rf levels
was found to yield more abundant oligosaccharide quasimo-
lecular ions. As shown in Figure 2c, the rf amplitude of 100−
150 V for the first funnel and 60 V for the second ion funnel
gave the strongest quasimolecular ion signal. Consequently, the
rf amplitudes of 100 and 60 V, respectively, were used for the
analysis. Under the optimized conditions, the instrument
yielded the strongest quasimolecular ion with the least amount
of fragmentation (Figure 1b).
Multiple Reaction Monitoring of Human Milk Oligo-
saccharides. MRM Transitions for HMOs. The MRM method
requires intense and reproducible fragment ions in order to
achieve high specificity and sensitivity. HMO fragmentations
employing CID were studied to obtain the optimum MRM
transitions for HMO quantitation. The tandem MS of several
compounds are provided for illustrative purposes in Supporting
Information Figure S-1. The most abundant fragment ions of
protonated HMO precursor were small mono-, di-, and some
trisaccharide fragments including m/z 366.2 (GlcNAc−Gal),
204.1 (N-acetylglucosamine, GlcNAc), 183.1 (glucose, Glc,
reducing end), 512.2 (Fuc−GlcNAc−Gal), 292.1 (N-acetyl-
neuraminic acid, Neu5Ac), and 657.1 (Neu5Ac−GlcNAc−
Gal). At least two of these abundant fragment ions were
monitored for each compound. The collision energy was
optimized for composition to yield the highest response. The
collision energy was then applied to a specific mass eluting at a
specific time. As listed in Supporting Information Table S-1, 42
HMOs, corresponding to 32 distinct masses were monitored.
This represents a large fraction of the total HMOs in
individuals corresponding to over 95% of the abundances.36
Dynamic MRMs. MRM detects multiple transitions
sequentially in one duty cycle. Transitions monitored within
a single duty cycle are called concurrent transitions. The dwell
time and cycle time are two important parameters in an MRM
method. The cycle time is the time spent monitoring all
transitions during one duty cycle, and the dwell time is the time
spent on acquiring one specific MRM transition within each
duty cycle. A long cycle time will result in poor LC peak
sampling and thus poor data quality, while a short dwell time
Figure 3. Extracted MRM chromatogram. The MRM transitions monitored are provided in Supporting Information Table S-1. Peaks are labeled
with corresponding structures. Structures in parentheses mean they could not be specifically resolved or identified. (a) The total dynamic MRM
chromatogram monitored for a pooled human milk oligosaccharide sample. Nine abundant HMO compounds can be readily identified and
annotated. (b) Lower abundant HMOs are identified and annotated: blue circles, Glc (glucose); yellow circles, Gal (galactose); blue squares,
GlcNAc (N-acetylglucosamine); yellow squares, GalNAc (N-acetylgalactosamine); red triangles, Fuc (fucose); purple diamonds, Neu5Ac (N-
acetylneuraminic acid).
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will result in poor signal-to-noise ratios (S/N). As the number
of concurrent MRM transitions increase, either the cycle time
needs to be increased resulting in poor data quality or the dwell
time needs to be decreased resulting in poor S/N. In order to
reduce the number of concurrent transitions, a dynamic MRM
method was employed whereby specific transitions are only
monitored at specific times, i.e., when the compound elutes.
The cycle time of the dynamic MRM method was set in these
analyses to 500 ms with the minimum and maximum dwell
times of 15.33 and 248.63 ms, respectively, resulting in between
30 and 60 points across a chromatographic peak. Figure 3
shows the dynamic MRM transitions monitored for a pooled
HMO sample. The abundant HMOs were annotated in Figure
3a. The lower abundant HMOs were annotated in Figure 3b.
The extracted ion chromatograms are provided separately in
Supporting Information Figure S-2. The isomers were well-
resolved using the PGC stationary phase. Homologues that
coelute have different masses and were readily distinguished
with MS.
Limits of Detection and Quantitation. Limits of detection
and the range of quantitation were studied for the standard
samples, which include two neutral (LNT and LNH), two
fucosylated (2′-FL and LNFP-I), and three sialylated HMOs
(6′-SL, 3′-SL, and LSTc). The limits of detection (LOD, S/N
≥ 3) for these compounds were at low-femtomole levels (10−
150 fmol), and the limits of quantitation (LOQ, S/N ≥ 6) were
at high-femtomole levels (100−1500 fmol) (Table 1). The
LOD for the neutral HMOs were slightly better than for the
sialylated HMOs. The reason may be due to the lower
ionization efficiency of sialylated species or a greater degree of
postsource fragmentation compared to the neutral compounds
in positive mode ESI.42 The HMOs show good linearity (R2 >
0.99 for over 2 orders of magnitude); however, quantitation can
be performed over 5 orders of magnitude using a quadratic
calibration curve (0.001−500 μg/mL, Supporting Information
Figures S-3 and S-4).
HMO Response Factor. The standard calibration curves for
seven HMO standards, LNT, 2′-FL, LNFP-I, LNH, 6′-SL,
LSTc, and 3′-SL, are illustrated in Supporting Information
Figure S-3. With the exception of LNT and 3′-SL, the response
factors (the slopes of the standard calibration curves) of the
HMOs are similar, within a factor of 2 (Table 2). The response
factor for LNT is higher compared to 2′-FL, LNFP-I, LNH, 6′-
SL, and LSTc, while the response factor of 3′-SL is the lowest.
Variations in ionization efficiencies and fragmentation
efficiencies are two possible reasons for these differences.
However, because HMO standards are very expensive and
often unavailable, a universal response factor to quantify each
component and the total HMO content would be desirable. To
this end, a linear regression equation, y = 6966.4x − 1752.6,
was created to correlate the MRM responses (y, ion counts) to
the HMO concentration (x, μg/mL) by averaging the slopes
and y-intercepts of the linear regression equations using the
seven HMO standards.
This equation was then used to quantify the total HMO
content of a pooled HMO sample. The pooled HMO sample
was collected and extracted from milks of several mothers.
Milligrams of extracted HMOs were then reduced, lyophilized,
weighed using a microbalance, reconstituted in Nanopure
water, and analyzed. Using this average linear regression
equation, the total HMO content was determined to be 2.2 ±
0.1 (SE) mg/mL compared to the actual sample value of 2.0
mg/mL. The average response factor can therefore be used to
obtain the total quantity of HMO in milk. The average
response factor was evaluated for each individual compound.
For the group of compounds that were used to obtain the
average response factor, the difference of concentration using
two different linear regression equations was within ±20% for
most of the standards. For LNT, the compound was
overestimated by 80%, whereas 3′-SL was underestimated by
70% as shown in Table 2. Nonetheless, using the average
response factor produces sufficiently accurate result for each
individual compound.
Validation of Matrix Effect with Standard Addition. To
evaluate the matrix effect in this ESI LC−MS experiment,
standard additions were performed by adding varying
concentrations of pure HMO standards into a pooled HMO
sample. Standard addition takes the matrix effect into account
and may provide more accurate values compared to a standard
curve. As illustrated in Table 1, the concentrations obtained
using these two different methods were found to differ by only
±10% except for 3′-SL (−38%). Ion suppression and ion
enhancement are the two major reasons for recovery rate
higher and lower than 100%, respectively. Nevertheless, the
result shows that the matrix effect is not a major source of error
in our experiments.
Quantitation of HMO in Biological Samples. Absolute
Quantitation of HMOs in Human Milk. To evaluate the
variation in absolute HMO concentrations in a general
population, the method was applied to milk samples collected
from 20 mothers on day 35 postpartum. The absolute amounts
of 2′-FL, LNT, LNFP-I, 3′-SL, 6′-SL, and LSTc in these 20
milk samples were determined (Table 2) using the standard
calibration curves depicted in Supporting Information Figure S-
3. Average concentrations of LNT and 2′-FL were 0.97 ± 0.56
and 1.5 ± 1.4 μg/mL, respectively, and are very close to
previously reported values.43,44 The standard deviation reflects
the biological diversity in these 20 samples. The LNFP-I, 3′-SL,
Table 1. Evaluation of Method Accuracy and Sensitivity
concn (mg/mL)a
compd standard calibration standard addition diff (%)b LOD (pmol) LOQ (pmol)
2′-FL 1.4 ± 0.1 1.6 ± 0.1 −15 0.017 0.17
LNFP-I 0.24 ± 0.05 0.26 ± 0.01 −6.9 0.0097 0.097
LNT 1.0 ± 0.1 0.95 ± 0.05 9.0 0.012 0.12
LNH 0.021 ± 0.004 0.020 ± 0.001 7.5 0.047 0.47
3′-SL 0.25 ± 0.01 0.40 ± 0.05 −39 0.13 1.3
6′-SL 0.18 ± 0.01 0.18 ± 0.01 −2.2 0.13 1.3
LSTc 0.063 ± 0.003 0.072 ± 0.015 −12 0.083 0.83
aStandard errors from the linear regression were reported. bThe difference in concentration obtained from standard calibration curves and from the
standard addition.
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Table 2. Absolute HMO Concentration for 10 Secretors and 10 Nonsecretors on Day 35 Postpartum Using Standard and
Universal Calibration Curves
concn in milk (mg/mL)
standard calibration curveb universal calibration curvec
compda mass (Da) RT (min) nonsec. sec. nonsec. sec. concn diff (%)d
2′-FL 490.2 13.6 (4.8 ± 10.5) × 10−1 2.5 ± 0.7 (5.8 ± 12.4) × 10−1 3.0 ± 0.8 20
3000 a 506.2 11.7 (6.2 ± 2.1) × 10−2 (4.2 ± 1.5) × 10−2
3000 b 506.2 12.1 (1.2 ± 0.5) × 10−2 (1.2 ± 0.6) × 10−2
3000 c 506.2 15.8 (5.6 ± 0.2) × 10−3 (5.5 ± 0.1) × 10−3
3′-SL 635.2 27.0 (1.8 ± 0.1) × 10−1 (1.7 ± 0.4) × 10−1 (5.3 ± 0.8) × 10−2 (4.9 ± 1.0) × 10−2 −71
6′-SL 635.2 17.5 (3.2 ± 0.7) × 10−1 (2.9 ± 1.1) × 10−1 (2.8 ± 0.6) × 10−1 (2.5 ± 1.0) × 10−1 −14
LDFTe 636.3 15.9 (1.9 ± 3.2) × 10−2 (9.7 ± 4.2) × 10−2
6′-SLNe 676.3 17.5 (6.4 ± 0.3) × 10−3 (6.5 ± 0.5) × 10−3
LNT 709.3 15.5 1.2 ± 0.7 (7.5 ± 3.1) × 10−1 2.2 ± 1.3 1.3 ± 0.6 80
LNnT 709.3 15.7 (2.2 ± 1.5) × 10−1 (3.6 ± 1.4) × 10−1
3110a 855.3 11.5 (1.3 ± 0.5) × 10−1 (1.2 ± 0.3) × 10−1
LNFP II 855.3 11.9 (5.6 ± 2.9) × 10−1 (1.1 ± 0.7) × 10−1
LNFP-I 855.3 14.9 (8.9 ± 23.8) × 10−2 (4.2 ± 2.1) × 10−1 (1.0 ± 2.7) × 10−1 (4.8 ± 2.4) × 10−1 14
LNFP-V 855.3 16.0 (1.4 ± 0.7) × 10−2 (2.0 ± 1.0) × 10−2
LSTc 1000.4 25.0 (5.0 ± 1.4) × 10−2 (5.5 ± 2.2) × 10−2 (3.8 ± 0.9) × 10−2 (4.2 ± 1.5) × 10−2 −24
LSTa 1000.4 26.8 (2.7 ± 1.0) × 10−2 (2.1 ± 1.1) × 10−2
LNDFH Ie 1001.4 11.4 (6.6 ± 3.0) × 10−3 (5.0 ± 1.6) × 10−3
LNDFH IIe 1001.4 11.5 (7.2 ± 7.0) × 10−3 (1.8 ± 0.8) × 10−2
3120 a 1001.4 12.0 (9.5 ± 3.8) × 10−3 (5.4 ± 3.1) × 10−3
LNH 1074.4 18.5 (4.3 ± 2.1) × 10−2 (5.0 ± 1.8) × 10−2 (4.8 ± 2.2) × 10−2 (5.1 ± 1.7) × 10−2 9
LNnH 1074.4 19.1 (2.1 ± 1.4) × 10−2 (4.0 ± 2.1) × 10−2
3220 a 1204.5 11.9 (2.7 ± 1.2) × 10−2 (9.5 ± 2.6) × 10−3
3220 b 1204.5 11.6 (1.0 ± 0.2) × 10−2 (1.0 ± 0.2) × 10−2
MFLNH IIIe 1220.5 17.1 (1.6 ± 0.4) × 10−1 (9.6 ± 2.8) × 10−2
MFLNH Ie 1220.5 17.3 (1.5 ± 3.4) × 10−2 (5.1 ± 3.1) × 10−2
IFLNH IIIe 1220.5 18.0 (3.9 ± 1.5) × 10−2 (5.2 ± 2.1) × 10−2
4300 1277.5 17.1 (1.6 ± 0.2) × 10−2 (1.4 ± 0.2) × 10−2
S-LNH 1365.5 26.0 (2.3 ± 0.8) × 10−2 (3.6 ± 1.6) × 10−2
4201 b 1365.5 25.5 (3.4 ± 0.9) × 10−2 (2.6 ± 0.5) × 10−2
4220 a 1366.5 14.3 (5.9 ± 2.4) × 10−2 (5.6 ± 2.4) × 10−2
DFLNH be 1366.5 14.5 (1.5 ± 0.9) × 10−1 (2.6 ± 1.2) × 10−2
DFLNH ae 1366.5 16.0 (2.5 ± 4.8) × 10−2 (1.0 ± 0.6) × 10−1
DFLNH ce 1366.5 20.3 (5.8 ± 3.7) × 10−3 (7.9 ± 0.9) × 10−3
4211 a 1511.6 23.1 (8.4 ± 1.5) × 10−3 (8.3 ± 1.2) × 10−3
4211 b 1511.6 23.7 (1.4 ± 0.6) × 10−2 (6.1 ± 2.1) × 10−3
4211 c 1511.6 24.0 (6.3 ± 4.9) × 10−3 (1.3 ± 0.8) × 10−2
4211 d 1511.6 25.5 (8.0 ± 2.3) × 10−2 (6.6 ± 1.3) × 10−2
TFLNHe 1512.6 14.4 (1.0 ± 1.4) × 10−2 (2.3 ± 1.0) × 10−2
4230 a 1512.6 19.8 (5.6 ± 3.5) × 10−3 (7.3 ± 3.0) × 10−3
5310 1585.6 19.2 (2.8 ± 1.2) × 10−2 (2.2 ± 0.8) × 10−2
4221 a 1657.6 24.4 (5.9 ± 4.1) × 10−3 (7.6 ± 2.7) × 10−3
4221 b 1657.6 27.0 (5.4 ± 2.9) × 10−3 (7.5 ± 1.6) × 10−3
5320 a 1731.6 18.1 (2.9 ± 1.2) × 10−2 (1.1 ± 0.2) × 10−2
5320 b 1731.6 18.3 (6.3 ± 5.4) × 10−3 (1.2 ± 0.4) × 10−2
5320 c 1731.6 19.2 (8.3 ± 1.3) × 10−3 (7.9 ± 2.8) × 10−3
5320 d 1731.6 19.4 (6.9 ± 6.7) × 10−3 (1.5 ± 0.4) × 10−2
5320 e 1731.6 20.8 (5.9 ± 4.4) × 10−3 (7.8 ± 1.6) × 10−3
6410 a 1950.7 22.6 (6.8 ± 6.5) × 10−3 (1.2 ± 0.4) × 10−2
6410 b 1950.7 22.9 (1.1 ± 0.3) × 10−2 (1.0 ± 0.3) × 10−2
total HMO content 5.1 ± 1.6 6.8 ± 0.7
aMonosaccharide composition, e.g., 5(Hex):3(HexNAc):2(Fuc):1(Neu5Ac) was represented as 5321 (Hex, hexose; HexNAc, N-acetylhexosamine;
Fuc, fucose; Neu5Ac, N-acetylneuraminic acid). bConcentration was obtained using specific standard calibration curves. The linear regression
equations used were as follows: (2′-FL) y = 8082x + 20297, R2 = 0.996; (LNFP-I) y = 7851x − 452, R2 = 1.000; (LNT) y = 12880x − 14067, R2 =
1.000; (LNH) y = 6710x − 547, R2 = 1.000; (3′-SL) y = 1895x − 564, R2 = 0.999; (6′-SL) y = 5686x − 795, R2 = 1.000; (LSTc) y = 4615x − 218, R2
= 1.000; nonsec., milk from nonsecretor mothers; sec., milk from secretor mothers. cConcentration was obtained using the average linear regression
equation, y = 6966.4x − 1752.6, fitted to the 0.8−100 μg/mL concentration window. dThe difference in concentration obtained from the standard
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6′-SL, and LSTc concentrations measured by our LC−MS
method were 20%−65% lower than that for HPAEC-PAD,44
well within biological variations. The LNFP-I concentration
reported previously using single-quadrupole LC−MS using
abundances and a calibration curve yielded a range of 0.001−
1.80 mg/mL,43 which includes our value 0.26 ± 0.28 mg/mL
(mean ± SD).
HMO Abundance and Secretor Status. It is known that the
secretor status of the mother largely influences her HMO
profile.36,44,45 Milk from secretor mothers contains a higher
percentage of α(1−2)-fucose in compounds such as 2′-FL and
LNFP-I as a consequence of the fucosyltransferase 2 (FUT2)
gene in the epithelial cells. Indeed, we find the abundances of
2′-FL and LNFP-I are significantly higher in secretors (2′-FL,
3.0 mg/mL; LNFP-, 0.48 mg/mL) than in nonsecretors (2′-FL,
0.58 mg/mL; LNFP-I, 0.10 mg/mL) (Figure 4 and Table 2).
We have previously suggested to use these compounds to
phenotype the mother based on her milk HMO.36 The results
depicted in Figure 4, parts a and b, however, show that a single
compound may be insufficient to completely separate secretors
from nonsecretors. For example, there are two nonsecretor
mothers in Figure 4a (mothers D1036 and D1041) who
produced 2′-FL abundances of the same magnitude as the
secretor mothers; however, the fraction of all HMOs with α(1−
2)-fucose is lower than those for secretor mothers. For other
abundant oligosaccharides such as LNT, LNH, 3′-SL, 6′-SL,
and LSTc, there appears no significant difference between the
two phenotypes (Figure 4c−g).
The concentrations for the individual compounds, also the
total HMO content, from the universal response factors are
listed in Table 2. The standard deviations in this table represent
the biological variation. The total amounts of HMOs were
found to be higher in the secretor (6.8 ± 0.7 mg/mL)
compared to the nonsecretor mothers (5.1 ± 1.6 mg/mL). The
difference was statistically significant (Figure 4h, P = 0.014 from
Mann−Whitney−Wilcoxon test) and consistent with a recent
report on Gambian mothers.36 Furthermore, the biological
variation in total HMO content among nonsecretor mothers is
larger than among secretor mothers, which was also found for
Gambian mothers.36
■ CONCLUSIONS
MRM is highly suited for the absolute quantitation of
oligosaccharides, specifically human milk oligosaccharides.
The limit of quantitation is approximately in the high-
femtomole level with the quantitation range spanning 5 orders
of magnitude. The small number of standards is typical in for
oligosaccharides, because the syntheses of specific structures,
even as small as those found in milk, remain a major task. This
issue will not soon be solved. We therefore examined the use of
a universal response factor based on the average of seven
compounds. Accurate absolute quantitation, while desirable, is
not often always needed. For many studies such as those for
discovering markers of health or diseases states, sample sets are
often matched and analyzed simultaneously. Relative quantita-
tion is therefore generally sufficient. The advantage of absolute
quantitation is that the value is generally independent of the
method. MRM is attractive nonetheless because it provides
both relative quantitation and, when standards are available,
absolute quantitation. A general response factor for HMO may
be helpful because it provides a good approximate value for a
component even when standards are not available but provide
values that can be directly compared for relative quantitation. A
general response factor is also useful for obtaining accurate
values for the total amounts of HMOs. This method will be of
general use in oligosaccharide analyses but specifically in
studying the bioactivity of HMOs.
■ ASSOCIATED CONTENT
*S Supporting Information
Additional information as noted in text. This material is
available free of charge via the Internet at http://pubs.acs.org.
Table 2. continued
curves and the average standard curves. e6′-SLN, 6′-sialyllactosamine; DFLNH, difucosyllacto-N-hexaose; IFLNH, isomeric fucosylated lacto-N-
hexaose; LDFT, lacto-difucotetraose; LNDFH, lacto-N-difucohexaose; MFLNH, monofucosyllacto-N-hexaose; TFLNH, trifucosyllacto-N-hexaose.
Figure 4. Box-and-whisker diagrams for secretor mothers (S) and
nonsecretor mothers (N) reveal that nonsecretor mothers produce
lower amounts of 2′-FL (P < 0.001) and LNFP-I (P = 0.004) than
secretor mothers. However, there are some outliers who still produce
similar amounts of 2′-FL or/and LNFP-I with secretor mothers, while
their total α(1−2) fucosylation is still at relatively low level. The total
HMO content produced by nonsecretor mothers is also lower (P =
0.014, Mann−Whitney−Wilcoxon test) than that of secretor mothers
using the nonparametric test. (a) 2′-FL. (b) LNFP-I. (c) LNT. (d)
LNH. (e) 6′-SL. (f) 3′-SL. (g) LSTc. (h) Total HMO content.
Reported P-values are from one-tail Student t test unless specified.
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